{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:34:15Z","timestamp":1757777655220},"reference-count":27,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec><jats:title>Objectives\/Hypothesis<\/jats:title><jats:p>Symptomatic bleeding among patients with advanced upper aerodigestive tract tumor is a challenging problem. Given the limited options for topical treatment, embolization is often required to control the hemorrhage. There are recent reported cases of novel and successful treatment of patients with recalcitrant tracheo\u2010bronchial bleed with tranexamic acid. We therefore described our initial experience of four consecutive cases of patients with bleeding from advanced aerodigestive tract tumor, successfully treated with oral tranexamic acid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design<\/jats:title><jats:p>Case series.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Case series of four consecutive patients with acute bleed from upper aerodigestive tract tumors, treated with oral tranexamic acid. Tranexamic acid was administered topically and systemically (1gm PO QID) for the orophayngeal and supraglottic tumor cases, where as systemic\u2010only therapy were administered to the patients with nasal and nasopharyngeal tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>None of the patients experienced further bleeding following the commencement of tranexamic acid treatment, and no adverse effect was noted. These are the first reported cases of symptomatic upper aerodigestive hemorrhage being controlled with tranexamic acid. It is increasingly being used in patients with life\u2010threatening bleeding following trauma and major surgery. The optimum dose of tranexamic acid is undetermined. In vivo studies suggested concentrations of 10 \u03bcg\/mL to 16 \u03bcg\/mL for optimal anti\u2010fibrinolytic effect, which is achievable with 1gm QID of oral administration. Large randomized controlled trials assessing the utility of tranexamic acid in various orthopedic surgeries did not show increased thromboembolic events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Tranexamic acid should be considered for patients with symptomatic nonarterial bleeding of the upper aerodigestive tract tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Level of Evidence<\/jats:title><jats:p>4. <jats:italic>Laryngoscope<\/jats:italic>, 123:2449\u20132452, 2013<\/jats:p><\/jats:sec>","DOI":"10.1002\/lary.24064","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T15:02:28Z","timestamp":1364828548000},"page":"2449-2452","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of bleeding upper aerodigestive tract tumor\u2014A novel approach with antifibrinolytic agent"],"prefix":"10.1002","volume":"123","author":[{"given":"Tsu\u2010Hui (Hubert)","family":"Low","sequence":"first","affiliation":[{"name":"Sydney Head and Neck Cancer Institute Royal Prince Alfred Hospital Camperdown Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnson","family":"Huang","sequence":"additional","affiliation":[{"name":"Sydney Head and Neck Cancer Institute Royal Prince Alfred Hospital Camperdown Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Reid","sequence":"additional","affiliation":[{"name":"ENT Department John Hunter Hospital New Lambton Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Elliott","sequence":"additional","affiliation":[{"name":"Sydney Head and Neck Cancer Institute Royal Prince Alfred Hospital Camperdown Australia"},{"name":"Medical School University of Sydney Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.","family":"Clark","sequence":"additional","affiliation":[{"name":"Sydney Head and Neck Cancer Institute Royal Prince Alfred Hospital Camperdown Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-5-561"},{"key":"e_1_2_7_3_1","first-page":"140","article-title":"CT angiography before embolization for hemorrhage in head and neck cancer","volume":"24","author":"Goodman D","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60939-7"},{"key":"e_1_2_7_5_1","unstructured":"MIMS Online. Cyklokapron (Tranexamic acid). In: Pfizer Australia;https:\/\/www.mimsonline.com.au.acs.hcn.com.au. Accessed October 12 2012."},{"key":"e_1_2_7_6_1","first-page":"CD001886","article-title":"Anti\u2010fibrinolytic use for minimising perioperative allogeneic blood transfusion","author":"Henry D","year":"2011","journal-title":"Cochrane Databse Syst Rev"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3054"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181f20177"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc10143"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.93B1.24984"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-011-1874-2"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep314"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.G.01179"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318210fd8f"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31821ab9f8"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5701"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61477-8"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60278-X"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2011.287"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050470"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2011.s11109"},{"key":"e_1_2_7_22_1","unstructured":"WHO Model Lists of Essential Medicines. [cited 2012 12 Oct 2012]; Available from:http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en&sol. Accessed October 12 2012."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.33.Suppl_14.41"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0936-y"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181e2914d"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01479.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.I.01518"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01637.x"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flary.24064","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.24064","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lary.24064","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.24064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T19:06:50Z","timestamp":1692472010000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lary.24064"}},"subtitle":["Case series and literature review"],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1002\/lary.24064"],"URL":"https:\/\/doi.org\/10.1002\/lary.24064","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}